Alcohol Use Disorder

Summarizes the evidence regarding the efficacy, comparative effectiveness, and adverse effects of medications in adults with AUD

Systematically reviews 156 trials, finding the best evidence of effectiveness for acamprosate, disulfiram, baclofen, and oral naltrexone among patients with alcohol use disorder supporting the expanded use of these medications in the clinical setting

Pahola is PAHO's first artificial intelligence (AI) health specialist and the only AI digital health worker in the world that specializes in alcohol-related topics. Pahola can communicate interactively - in three languages (English, Portuguese, and Spanish) - with people about their alcohol consumption, assess their risk, help them reduce or stop alcohol use, or direct them to resources for treatment and recovery

Qualitative literature review that discusses disulfiram, acamprosate, naltrexone, nalmefene, topiramate, gabapentin, and several other medications for the treatment of alcohol use disorder, which have demonstrated some clinical effectiveness

A review of the literature on clinical trials on pharmacotherapies for alcohol use disorder, noting that topiramate and gabapentin have been used and that baclofen and nalmefene have been approved in some other countries

A video series called “Short Takes with NIAAA” featuring commentary by NIAAA experts; this series consists of social media-friendly, 60-second videos explaining commonly used—but often misunderstood—alcohol terms

Reviews the literature and data on outcomes for medication-assisted treatment for alcohol use disorder in inpatient settings using naltrexone

This study aimed to systematically review and synthesize the research evidence about the efficacy of mHealth interventions on various health outcomes for consumer self-control of unhealthy alcohol use and to identify the core components to achieve these outcomes

Provides information to consumers on medicines to treat alcohol use disorder